Table 3 Clinical characteristics of gastric cancer patient
From: A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer
Training set (n = 50) | Validation set (n = 58) | Random set (n = 15) | P value | Total (n = 123) | |
|---|---|---|---|---|---|
Age [years; mean (SD)] | 62.8 (18.3) | 67.2 (16.4) | 67.1 (13.4) | 0.366 | 64.40 (16.88) |
Sex | 0.499 | ||||
Men | 31 | 33 | 11 | 75/123 (61 %) | |
Women | 19 | 25 | 4 | 48/123 (39 %) | |
Depth of invasion (T) | 0.932 | ||||
T1 | 7 | 4 | 2 | 13/123 (11 %) | |
T2 | 12 | 13 | 3 | 28/123 (23 %) | |
T3 | 18 | 25 | 6 | 49/123 (40 %) | |
T4 | 13 | 16 | 4 | 33/123 (27 %) | |
Lymph-node metastasis | 0.361 | ||||
(N) | 13 | 10 | 4 | 27/123 (22 %) | |
N0 | 10 | 8 | 2 | 20/123 (16 %) | |
N1 | 26 | 40 | 8 | 74/123 (60 %) | |
N2 | 1 | 0 | 1 | 2/123 (2 %) | |
N3 | |||||
Distant metastasis | 0.554 | ||||
No | 37 | 46 | 13 | 96/123 (78 %) | |
Yes | 13 | 12 | 2 | 27/123 (22 %) | |
Stage | 0.088 | ||||
I | 8 | 8 | 4 | 20/123 (16 %) | |
II | 11 | 2 | 2 | 15/123 (12 %) | |
III | 15 | 26 | 5 | 46/123 (38 %) | |
IV | 16 | 22 | 4 | 42/123 (34 %) |